Lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors may be at increased risk of adverse events after receiving the seasonal influenza vaccination, according to the first study measuring this effect. The results, presented today at the European Lung Cancer Conference (ELCC) 2017 in Geneva, Switzerland, offer the first hint of a possible contraindication with two...